media – Page 632 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Plexus TG and Codonics to integrate anaesthesia safety technology

Medication management systems provider Plexus Technology Group (TG) is set to integrate its anaesthesia information management system (AIMS) with medical imaging firm Codonics’ medication safety technology Safe Label System (SLS) for an improved anaesthesia process.

Source: Medicaldevices-network.com
365
August 1, 2017

Echemi Pharma Forum , A Face-to-Face Meeting in Pharma Asia

Pharma Asia 2017 Pharma Asia is a 3 day event being held from 22nd August to the 24th August 2017 at the Karachi Expo Center in Karachi, Pakistan. This event showcases products like providing investors with a definite outlook of the regional pharmaceutical industry and an opportunity to meet their prospective counterparts and business partners etc. in the Medical & Pharmaceutical industry. Echemi Pharma Forum: From August 22 to 24, Echemi will attend Pharma Asia exhibition, and will take other three Chinese companies to this exhibition. On one side, for visitors, this is a good chance for them to know suppliers and choose their needs directly. On the other side, for suppliers, this is an opportunity to show their products and let more people know their companies. During exhibition period, Echemi will hold “Pharma Forum & Procurement Conference”, which is a face-to-face meeting for suppliers and buyers. There will be ...

Source: Echemi
521
August 1, 2017

Echemi Exhibitions & Activities ZT League Chemical

Countdown！Ddu to attend the America AACC

The 69th Annual Scientific Meeting and Clinical Lab Exposition (AACC) will be held in Orlando, USA from August 1st to August 3rd, 2017.

Source: Ddu
662
July 31, 2017

AACC Exhibitions & Activities medical device

AZ, Merck link to develop and commercialise cancer drugs

AstraZeneca and Merck & Co have announced a global strategic oncology collaboration to co-develop and co-commercialise the former’s Lynparza and selumetinib for multiple cancer types.

Source: pharmatimes
490
July 31, 2017

cancer Lynparza Market Views Researches therapy

EU approves CV benefit claim for Novo’s Victoza

Novo Nordisk’s diabetes drug Victoza is now approved in Europe as the only GLP-1 analogue with a label including prevention of cardiovascular events.

Source: pharmatimes
432
July 31, 2017

cardiovascular Company Insight diabetes New Approvals

Medtronic launches new MRI cardiac therapy defibrillators

Medtronic’s Canadian subsidiary has launched its new magnetic resonance imaging (MRI) conditional cardiac resynchronisation therapy defibrillators (CRT-Ds)

Source: Medicaldevices-network.com
509
July 31, 2017

cardiac Company Insight heart MRI

EU OKs first-line use of AZ’ Faslodex

EU regulators are permitting the use of AstraZeneca’s breast cancer drug Faslodex at an earlier stage of the treatment pathway in patients with certain forms of the disease.

Source: pharmatimes
759
July 28, 2017

breast cancer EU inhibitor New Approvals

Takeda and BioSurfaces to develop new medical devices for GI indications

Japan's Takeda Pharmaceutical Company has signed an agreement with US-based nanotechnology provider BioSurfaces to develop new therapeutic devices to treat gastrointestinal (GI) diseases.

Source: Medicaldevice-network
421
July 28, 2017

Company Insight gastrointestinal nanofibrous New Approvals

Sensus gets Chinese regulatory approval for keloid device

US-based Sensus Healthcare has received approval from the China Food and Drug Administration (CFDA) to commercialise its keloid prevention and treatment device, SRT-100. The tool is designed to deliver a precise and calibrated dose of superficial radiation therapy to ensure a skin deep and safe treatment for patients. The low-dose radiation is intended to destroy keloid-causing non-malignant tumour cells, basal cell carcinoma and squamous cell carcinoma without the use of anaesthesia, risk of infection, scarring or the need for reconstructive plastic surgery. Sensus intends to introduce SRT-100 into the country’s market in the fourth quarter of this year through its Chinese partner Chindex Medical, which is a division of Fosun Pharma International. The device will focus on prevention and treatment of keloids associated with Cesarean sections (C-sections). Sensus Healthcare CEO Joe Sardano said: “CFDA clearance of the SRT-100 for the treatment and prevention of keloids is an important milestone for ...

Source: Medicaldevice-network
447
July 28, 2017

CFDA Company Insight keloid New Approvals

ViiV’s long-acting two-drug HIV regimen hits targets

A long-acting, two-drug HIV regimen being co-developed by ViiV Healthcare and Janssen Sciences Ireland UC has shown comparable viral suppression rates to a three-drug regimen in a Phase II trial, indicating its potential to reduce the dosing burden for patients and thus improve treatment adherence. The LATTE-2 study assessed long-acting, injectable formulations of cabotegravir (ViiV) and rilpivirine (Janssen, branded Edurant), given every four or eight weeks to patients with HIV-1 infection who had already achieved viral suppression with a daily three-drug oral regimen of cabotegravir plus two nucleoside reverse transcriptase inhibitors (NRTIs). Following 96 weeks of maintenance treatment, viral suppression rates for the two-drug regimen dosed every eight weeks (94 percent) or every four weeks (87 percent) were comparable to the rate observed in patients continuing with a three-drug oral regimen (84 percent). In the study, data from which were published in The Lancet and presented at the annual conference ...

Source: Medicaldevice-network
508
July 27, 2017

Clinical Trials formulation HIV Researches

Plexus TG and Codonics to integrate anaesthesia safety technology

Echemi Pharma Forum , A Face-to-Face Meeting in Pharma Asia

Countdown！Ddu to attend the America AACC

AZ, Merck link to develop and commercialise cancer drugs

EU approves CV benefit claim for Novo’s Victoza

Medtronic launches new MRI cardiac therapy defibrillators

EU OKs first-line use of AZ’ Faslodex

Takeda and BioSurfaces to develop new medical devices for GI indications

Sensus gets Chinese regulatory approval for keloid device

ViiV’s long-acting two-drug HIV regimen hits targets

Trending Topics

Hot Tags

Subscribe

more

more

Customer Services

About Us

Buy on Drugdu.com

Sell on Drugdu.com

Blogroll

Free APP

Follow Us